Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization

Sponsor
Zydolab - Institute of Cytology and Immune Cytochemistry (Other)
Overall Status
Completed
CT.gov ID
NCT02515162
Collaborator
Ruhr University of Bochum (Other)
178
1
2
13
13.6

Study Details

Study Description

Brief Summary

In a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, two electrosurgical excision methods, Fischer Cone Biopsy Excison vs. Loop Excision Procedure, will be compared. The primary outcome of the study is dysplasia-free resection margin rate, secondary outcomes are intraoperative blood loss, time to complete hemostasis, intervention time, postoperative pain, intra- and postoperative complications, the resected cone volume and users satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Fischer Cone Biopsy Excisor
  • Procedure: Loop Excision Procedure
N/A

Detailed Description

Conization is the method of choice in therapy for cervical dysplasia. Beside the risk of preterm delivery, the risk of a local relapse in patients with dysplasia-affected resection margin is high.

The Goldstandard standard technique in conization for women with cervical dysplasia is the large loop excision of the transformation zone ("LLETZ"). Nevertheless other techniques such as the excision of the abnormal tissue with the so called "Fischer Cone Biopsy Excisor" could provide advantages and is yet not enough investigated. The loop excision technique uses a circular electrode, in contrast Fischer Cone Biopsy Excision is done by a triangular electrode.

It is unknown, whether the use of the circular or the triangular electrode is superior regarding the dysplasia-free resection margin rate and other outcome parameters such as the resected cone volume, postoperative bleeding and postoperative pain. Therefore, the investigator designed a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, comparing the two electrosurgical techniques, "LLETZ-conization" and "Fischer Cone Biopsy Excision". The primary outcome of the study is the dysplasia-free resection margin rate independently proved by a pathologist, secondary outcomes are intraoperative blood loss measured as difference in serum hemoglobin pre- and postoperatively, postoperative pain according to a 11 step VAS scale, time to complete hemostasis measured in seconds, duration of the intervention measured in minutes, resected cone volume, users satisfaction according to a 11 step VAS scale and intra- and postoperative complications, defined as necessity to intervene surgically up to 14 days postoperatively.

The study Population consists of women undergoing conization for histologically proven cervical dysplasia.

Study Design

Study Type:
Interventional
Actual Enrollment :
178 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Fischer Cone Biopsy Excisor Versus Loop Excision Procedure. A Randomized Trial of Two Operation Techniques in Women Undergoing Conization for Cervical Dysplasia
Study Start Date :
Jul 1, 2015
Actual Primary Completion Date :
Jul 1, 2016
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fischer Cone Biopsy Excisor

Conization Methode using a triangular electrode , i.e. Fischer Cone Biopsy Excisor

Procedure: Fischer Cone Biopsy Excisor
Electrosurgical excision method using a triangular electrode to remove the abnormal cervical Transformation zone

Active Comparator: Loop Excision Procedure

Conization Methode using a circular electrode , i.e. Loop excision Procedure

Procedure: Loop Excision Procedure
Electrosurgical excision method using a circular electrode to remove the abnormal cervical Transformation zone

Outcome Measures

Primary Outcome Measures

  1. Margin status [2 Days after conization]

    Resection margin is judge as "R0" if abnormal cells are not found in the margin of the biopsy or "R1" if abnormal cells remain in the margin of the biopsy. The histopathological examination will be done by an Independent pathologist

Secondary Outcome Measures

  1. Intraoperative blood loss [5 hours]

    intraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively

  2. Postoperative pain [5 hours]

    patients will score their postoperative pain Level using a 11-step visual analogue scale (nVAS) and a 5-step graphical visual analogue scale (gVAS)within 5 hours after surgery

  3. Time to complete intraoperative hemostasis [120 seconds]

    the time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds

  4. Operation time [20 minutes]

    the time from the beginning of the Operation (start of the electrosurgical method) until the end of the operation (the end of hemostatic interventions) will be measured in minutes

  5. Resected cone volume [10 minutes]

    The resected cone volume will be measured postoperative by using a scale

  6. satisfaction with the device [30 minutes]

    surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,satisfaction with the device' (ranging from 0 (,very satisfied') to 10 (,absolutely not satisfied')

  7. handling of the device [30 minutes]

    surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,(ranging from 0 (,very easy') to 10 (,very difficult')

  8. Operative complications [14 days]

    Operative complications defined as necessity to intervene surgically up to 14 days postoperatively

  9. number of fragments of the surgical specimen [10 minutes]

    surgeons will count the number of the surgical specimen (1 vs. >1)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • histologically proven cervical dysplasia

  • colposcopy Prior to conization

  • informed consent

  • no known hematologic disorder

Exclusion Criteria:
  • significant language barrier

  • a personal history of conization

  • pregnancy

  • the use of blood thinner

  • unwillingness to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Obstetrics and Gynecology of the Ruhr University Bochum Herne NRW Germany 44625

Sponsors and Collaborators

  • Zydolab - Institute of Cytology and Immune Cytochemistry
  • Ruhr University of Bochum

Investigators

  • Principal Investigator: Ziad Hilal, Dr. med., Zydolab - Institute of Cytology and Immune Cytochemistry

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. med. Ziad Hilal, Dr. med. Ziad Hilal, Zydolab - Institute of Cytology and Immune Cytochemistry
ClinicalTrials.gov Identifier:
NCT02515162
Other Study ID Numbers:
  • CONE-2
First Posted:
Aug 4, 2015
Last Update Posted:
Aug 16, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dr. med. Ziad Hilal, Dr. med. Ziad Hilal, Zydolab - Institute of Cytology and Immune Cytochemistry
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2016